Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia

Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia

Alopecia is an undesirable side effect of cancer chemotherapy. The mitigation of alopecia is a desirable adjunct treatment for patients with cancer. FDA-cleared scalp cooling (SC) devices have been successfully used to prevent or reduce chemotherapy-induced alopecia (CIA). This paper provides an und...

Full description

Saved in:
Bibliographic Details
Main Authors: Portia Lagmay-Fuentes, Andrea Smith, Shannon Krus, Laurie Lewis, Asma Latif, Tiffany Gagliardo, Manpreet Kohli
Format: Article
Language:English
Published: MDPI AG 2024-07-01
Series:Journal of Market Access & Health Policy
Subjects:
alopecia
insurance-based billing model
reimbursement
scalp cooling
self-pay
Online Access:https://www.mdpi.com/2001-6689/12/3/13
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2001-6689/12/3/13

Similar Items